107 related articles for article (PubMed ID: 15459403)
1. Modelling the healthcare costs of an opportunistic chlamydia screening programme.
Adams EJ; LaMontagne DS; Johnston AR; Pimenta JM; Fenton KA; Edmunds WJ
Sex Transm Infect; 2004 Oct; 80(5):363-70. PubMed ID: 15459403
[TBL] [Abstract][Full Text] [Related]
2. Healthcare and patient costs of a proactive chlamydia screening programme: the Chlamydia Screening Studies project.
Robinson S; Roberts T; Barton P; Bryan S; Macleod J; McCarthy A; Egger M; Sanford E; Low N;
Sex Transm Infect; 2007 Jul; 83(4):276-81. PubMed ID: 17229792
[TBL] [Abstract][Full Text] [Related]
3. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
Blake DR; Gaydos CA; Quinn TC
Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
[TBL] [Abstract][Full Text] [Related]
5. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
Gillespie P; O'Neill C; Adams E; Turner K; O'Donovan D; Brugha R; Vaughan D; O'Connell E; Cormican M; Balfe M; Coleman C; Fitzgerald M; Fleming C
Sex Transm Infect; 2012 Apr; 88(3):222-8. PubMed ID: 22213681
[TBL] [Abstract][Full Text] [Related]
6. Modelling the impact of opportunistic screening on the sequelae and public healthcare costs of infection with Chlamydia trachomatis in Australian women.
Ward B; Rodger AJ; Jackson TJ
Public Health; 2006 Jan; 120(1):42-9. PubMed ID: 16271271
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
[TBL] [Abstract][Full Text] [Related]
8. Evaluating adolescents in juvenile detention facilities for urogenital chlamydial infection: costs and effectiveness of alternative interventions.
Mrus JM; Biro FM; Huang B; Tsevat J
Arch Pediatr Adolesc Med; 2003 Jul; 157(7):696-702. PubMed ID: 12860793
[TBL] [Abstract][Full Text] [Related]
9. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].
Postma MJ; Welte R; van den Hoek JA; Jager JC; van Doornum GJ; Coutinho RA
Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2383-5. PubMed ID: 10590778
[TBL] [Abstract][Full Text] [Related]
10. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening.
LaMontagne DS; Fenton KA; Randall S; Anderson S; Carter P
Sex Transm Infect; 2004 Oct; 80(5):335-41. PubMed ID: 15459399
[TBL] [Abstract][Full Text] [Related]
11. Prediction of costs, effectiveness, and disease control of a population-based program using home sampling for diagnosis of urogenital Chlamydia trachomatis Infections.
Andersen B; Gundgaard J; Kretzschmar M; Olsen J; Welte R; Oster-Gaard L
Sex Transm Dis; 2006 Jul; 33(7):407-15. PubMed ID: 16601656
[TBL] [Abstract][Full Text] [Related]
12. Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme.
Nnoaham KE; Lines C
Gut; 2008 Sep; 57(9):1238-45. PubMed ID: 18441004
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of Chlamydia antibody tests in subfertile women.
Fiddelers AA; Land JA; Voss G; Kessels AG; Severens JL
Hum Reprod; 2005 Feb; 20(2):425-32. PubMed ID: 15539437
[TBL] [Abstract][Full Text] [Related]
14. The chlamydia screening studies: rationale and design.
Low N; McCarthy A; Macleod J; Salisbury C; Horner PJ; Roberts TE; Campbell R; Herring A; Skidmore S; Sanford E; Sterne JA; Davey Smith G; Graham A; Huengsberg M; Ross J; Egger M
Sex Transm Infect; 2004 Oct; 80(5):342-8. PubMed ID: 15459400
[TBL] [Abstract][Full Text] [Related]
15. Managing genital chlamydia trachomatis infection in Scotland: targeted opportunistic testing or a screening programme?
Clutterbuck DJ
Health Bull (Edinb); 2001 Nov; 59(6):396-404. PubMed ID: 12661390
[TBL] [Abstract][Full Text] [Related]
16. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
[TBL] [Abstract][Full Text] [Related]
17. A cost-effectiveness evaluation of a jail-based chlamydia screening program for men and its impact on their partners in the community.
Gift TL; Lincoln T; Tuthill R; Whelan M; Briggs LP; Conklin T; Irwin KL
Sex Transm Dis; 2006 Oct; 33(10 Suppl):S103-10. PubMed ID: 17003677
[TBL] [Abstract][Full Text] [Related]
18. Universal screening or prophylactic treatment for Chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective?
Chen S; Li J; van den Hoek A
Sex Transm Dis; 2007 Apr; 34(4):230-6. PubMed ID: 17414068
[TBL] [Abstract][Full Text] [Related]
19. 'Show me the money': financial incentives increase chlamydia screening rates among tertiary students: a pilot study.
Currie MJ; Schmidt M; Davis BK; Baynes AM; O'Keefe EJ; Bavinton TP; McNiven M; Martin SJ; Bowden FJ
Sex Health; 2010 Mar; 7(1):60-5. PubMed ID: 20152098
[TBL] [Abstract][Full Text] [Related]
20. The cost effectiveness of opportunistic chlamydia screening in England.
Adams EJ; Turner KM; Edmunds WJ
Sex Transm Infect; 2007 Jul; 83(4):267-74; discussion 274-5. PubMed ID: 17475686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
